Arbutus Biopharma - 1792 Exchange

Corporate Bias Rating

Expand Summary

Risk Level:

Lower Risk

Summary:

Arbutus Biopharma is Lower Risk. The company does not yield to political activism in shaping corporate governance, preventing initiatives that potentially alienate consumers, divide employees, and harm shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Overall, Arbutus Biopharma does not embrace corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach protects free exercise, free speech, and free enterprise.

View Full Corporate Bias Ratings Report

Criteria

Risk Level

Rationale

Corporate Weaponization

Criteria

Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level

Rationale

Arbutus Biopharma has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (1).

Criteria

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level

Rationale

Arbutus Biopharma does not appear to discriminate against charitable organizations based on views or beliefs (1)(2).

Criteria

Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.

Risk Level

Rationale

Arbutus Biopharma requires its employees to take unconscious bias and anti-harassment training (1). The company does not provide viewpoint protections for its employees (2).

Corporate Governance and Public Policy

Criteria

Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.

Risk Level

Rationale

Arbutus Biopharma supports DEI within its business practices. From its 2024 Annual Report: “Our commitment to diversity and inclusion is demonstrated by our placement of ultimate responsibility for diversity, equity and inclusion with our Board, informed by the recommendations of management and our Board’s Nominating and Governance Committee” (1). Otherwise, there are no publicly known cases of the company using its reputation to advance ideological causes or policies (2).

Criteria

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level

Rationale

Arbutus Biopharma has not used corporate funds to advance ideological causes, organizations, or policies (1).

Criteria

Uses corporate political actions and/or financial contributions for ideological, non-business purposes.

Risk Level

N/A

Rationale

Arbutus Biopharma does not operate a PAC or engage in lobbying at this time (1)(2)(3).

Board Bias

Expand Summary

1792 Exchange has not yet compiled data about the board of directors or political contributions of leadership for this company.